Product Comparison


  Tolmar Pharmaceuticals 62935030330 APP Pharmaceuticals 63323011710 Fresenius USA 63323011751 Teva 00703367501 Pfizer 61703035038
McKesson # 1019215 479124 788329 825593 918013
Description Eligard® Leuprolide Acetate 30 mg Injection 0.5 mL Fluorouracil 50 mg / mL Injection 10 mL Fluorouracil 50 mg / mL Injection 50 mL Methotrexate Sodium, Preservative Free 25 mg / mL Injection 10 mL Methotrexate Sodium 25 mg / mL Injection 2 mL
Manufacturer # 6293503033063323011710633230117510070336750161703035038
Brand Eligard®    
Manufacturer Tolmar PharmaceuticalsAPP PharmaceuticalsFresenius USATevaPfizer
Invoice ELIGARD KIT, SRY 30MG 4MONTHRXRXFLUOROURACIL, SDV 50MG/ML 10ML(10/CT)FLUOROURACIL, VL 2.5GM/50ML 50MLMETHOTREXATE, SDV 25MG/ML 10MLMETHOTREXATE, VL 25MG/ML 2ML (5/BX)
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 132726112815262004877
Container Type Single-Dose KitSingle-Dose VialPharmacy Bulk VialSingle-Dose VialVial
Country of Origin United StatesUnknownUnknownUnknownUnknown
Generic Drug Code 1921997455974571893638466
Generic Drug Name Leuprolide AcetateFluorouracilFluorouracilMethotrexate Sodium, Preservative FreeMethotrexate Sodium
NDC Number 6293503033063323011710633230117510070336750161703035038
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 days
Storage Requirements Requires Refrigeration
Strength 30 mg50 mg / mL50 mg / mL25 mg / mL25 mg / mL
Type SubcutaneousIntravenousIntravenousIntramuscular, Intravenous, or Intra-arterial
UNSPSC Code 5111180751442004514420045120220351202203
Volume 0.5 mL10 mL50 mL10 mL2 mL
Application Antineoplastic AgentAntineoplastic AgentAntineoplastic AgentAntineoplastic AgentAntineoplastic Agent
Dosage Form InjectionInjectionInjectionInjectionInjection
Features and Benefits
  • Each Kit Contains: 1 sterile syringe (Syringe A) pre-filled with the Atrigel® delivery system, 1 sterile syringe (Syringe B) pre-filled with leuprolide acetate powder, 1 long plunger rod for use with Syringe B, desiccant packs, 1 sterile safety needle
  • 1 Injection every 4 months
  • Methotrexate injection (preservative free) injectable products may be given by the intramuscular, intravenous, intra-arterial or intrathecal route
  • Contains preservative
  • Not for intrathecal or high-dose therapy
  • 5 vials supplied in each carton